Hanning Li

618 total citations
31 papers, 397 citations indexed

About

Hanning Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Hanning Li has authored 31 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Hanning Li's work include Ferroptosis and cancer prognosis (10 papers), RNA modifications and cancer (10 papers) and Epigenetics and DNA Methylation (5 papers). Hanning Li is often cited by papers focused on Ferroptosis and cancer prognosis (10 papers), RNA modifications and cancer (10 papers) and Epigenetics and DNA Methylation (5 papers). Hanning Li collaborates with scholars based in China, United States and France. Hanning Li's co-authors include Menglu Dong, Tao Xu, Xingrui Li, Yaying Du, Xingrui Li, Zheng‐tao Lv, Xiang Zhou, Linke Li, Haiyang Li and Thomas C. W. Mak and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Endocrinology and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Hanning Li

27 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanning Li China 15 210 105 85 69 50 31 397
Qisheng Su China 12 173 0.8× 105 1.0× 94 1.1× 66 1.0× 29 0.6× 45 437
Ze Gong China 7 250 1.2× 125 1.2× 101 1.2× 35 0.5× 22 0.4× 10 532
Jianfei Wen China 12 259 1.2× 125 1.2× 45 0.5× 97 1.4× 42 0.8× 36 546
Takahiro Ohmori Japan 12 139 0.7× 36 0.3× 32 0.4× 30 0.4× 41 0.8× 32 393
Sandrine Pacquelet France 12 133 0.6× 73 0.7× 39 0.5× 62 0.9× 18 0.4× 18 423
Gesche Tallen Germany 13 235 1.1× 37 0.4× 19 0.2× 244 3.5× 25 0.5× 27 652
Wanhua Lin China 8 152 0.7× 93 0.9× 26 0.3× 68 1.0× 12 0.2× 11 337
Chengxin Liu China 13 134 0.6× 89 0.8× 148 1.7× 98 1.4× 18 0.4× 59 558

Countries citing papers authored by Hanning Li

Since Specialization
Citations

This map shows the geographic impact of Hanning Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanning Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanning Li more than expected).

Fields of papers citing papers by Hanning Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanning Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanning Li. The network helps show where Hanning Li may publish in the future.

Co-authorship network of co-authors of Hanning Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hanning Li. A scholar is included among the top collaborators of Hanning Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanning Li. Hanning Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hanning, et al.. (2025). GGCT Inhibits Ferroptosis in PTC Cells by Upregulating p53 Through RPS15A. Cancer Science. 116(6). 1592–1603. 2 indexed citations
2.
Zhang, Wanjun, Jun Wang, Hanning Li, et al.. (2025). TAF7 directly targets SAA1 to enhance triple-negative breast cancer metastasis via phosphorylating E-cadherin and N-cadherin. iScience. 28(3). 111989–111989.
3.
Wang, Jun, Huimin Zhang, Guanhua Zhu, et al.. (2024). STT3-mediated aberrant N-glycosylation of CD24 inhibits paclitaxel sensitivity in triple-negative breast cancer. Acta Pharmacologica Sinica. 46(4). 1097–1110. 3 indexed citations
4.
Li, Xiangjun, et al.. (2024). Simulation and application analysis of a hybrid energy storage station in a new power system. Global Energy Interconnection. 7(5). 553–562. 2 indexed citations
5.
6.
Li, Shuyu, Nan Zhang, Hao Zhang, et al.. (2024). Deciphering the TCF19/miR-199a-5p/SP1/LOXL2 pathway: Implications for breast cancer metastasis and epithelial-mesenchymal transition. Cancer Letters. 597. 216995–216995. 1 indexed citations
7.
Wang, Ge, Yaying Du, Tao Xu, et al.. (2024). Directed differentiation of human embryonic stem cells into parathyroid cells and establishment of parathyroid organoids. Cell Proliferation. 57(8). e13634–e13634. 4 indexed citations
8.
Yang, Xue, Yonglin Wu, Hanning Li, et al.. (2023). Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery. BMC Endocrine Disorders. 23(1). 113–113. 6 indexed citations
9.
Li, Hanning, et al.. (2023). Beyond TORCH: A narrative review of the impact of antenatal and perinatal infections on the risk of disability. Neuroscience & Biobehavioral Reviews. 153. 105390–105390. 11 indexed citations
10.
11.
Yang, Xue, Ge Wang, Hanning Li, et al.. (2022). Regulation of antitumor miR-205 targets oncogenes: Direct regulation of lymphoid specific helicase and its clinical significance. Life Sciences. 309. 120993–120993. 1 indexed citations
12.
Li, Hanning, Xiang Zhou, Ge Wang, et al.. (2021). CAR-T Cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 107(4). 1110–1126. 27 indexed citations
13.
Li, Hanning, et al.. (2021). MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway. Cancer Management and Research. Volume 13. 2009–2024. 31 indexed citations
14.
Wang, Ge, Hanning Li, Tao Xu, et al.. (2021). S100A1 is a Potential Biomarker for Papillary Thyroid Carcinoma Diagnosis and Prognosis. Journal of Cancer. 12(19). 5760–5771. 16 indexed citations
15.
16.
Li, Hanning, Yaying Du, Tao Xu, et al.. (2020). TMEM158 May Serve as a Diagnostic Biomarker for Anaplastic Thyroid Carcinoma: An Integrated Bioinformatic Analysis. Current Medical Science. 40(6). 1137–1147. 4 indexed citations
17.
Xu, Tao, Menglu Dong, Zhi Wang, Hanning Li, & Xingrui Li. (2020). <p>Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer</p>. Cancer Management and Research. Volume 12. 5773–5786. 17 indexed citations
18.
Wang, Ya, Hanning Li, Jingjing Ma, et al.. (2019). <p>Integrated Bioinformatics Data Analysis Reveals Prognostic Significance Of SIDT1 In Triple-Negative Breast Cancer</p>. OncoTargets and Therapy. Volume 12. 8401–8410. 16 indexed citations
19.
Xu, Tao, Rui Zhang, Menglu Dong, et al.. (2019). <p>Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway</p>. OncoTargets and Therapy. Volume 12. 10639–10650. 43 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qisheng Su Breakdown of academic impact, for papers by Ze Gong Breakdown of academic impact, for papers by Jianfei Wen Breakdown of academic impact, for papers by Takahiro Ohmori Breakdown of academic impact, for papers by Sandrine Pacquelet Breakdown of academic impact, for papers by Gesche Tallen Breakdown of academic impact, for papers by Wanhua Lin Breakdown of academic impact, for papers by Chengxin Liu
Rankless by CCL
2026